Publications and Reports

TDRC 2009 - 2010 PUBLICATIONS   AND    2008 -2007 PUBLICATIONS

• Increased Risk for Severe Malaria in HIV-1–infected Adults, Zambia
  
  Jean-Pierre Van Geertruyden, Erika Van Eijk, Francisca Yosaatmadja, Webster Kasongo, Modest Mulenga, Umberto D'Alessandro, and Stephen Rogerson
  
  Malar J. 2009; 8: 258. Published online 2009 November 18.  
  
  
• Trichomonas vaginalis is Highly Prevalent in Adolescent Girls, Pregnant Women, and Commercial Sex Workers in Ndola, Zambia.
  
  Crucitti T, Jespers V, Mulenga C, Khondowe S, Vandepitte J, Buvé A.
  
  Sex Transm Dis. 2009 Nov 24.
  
  
  
• Plasmodium falciparum and Dihydrofolate Reductase I164L Mutations in Africa
  
  Victor Chalwe, Jean-Pierre Van geertruyden, Doreen Mukwamataba, Joris Menten, John Kamalamba, Modest Mulenga, and Umberto D’Alessandro
  
  Emerg Infect Dis. 2009 May; 15(5): 749–755.
  
  
  
• Alisa P. Alker, Jonathan J. Juliano, and Steven R. Meshnick
  
  Antimicrob Agents Chemother. 2009 April; 53(4):
  
  Authors' Reply
  
  Andrew Owen, Edwin Ochong, David J. Bell, David J. Johnson, Umberto d'Alessandro, Modest Mulenga, Sant Muangnoicharoen, J. P. Van Geertruyden, Peter A. Winstanley, Patrick G. Bray, and Stephen A. Ward
  
  
• Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial
  
  Quique Bassat, Modest Mulenga, Halidou Tinto, Patrice Piola, Steffen Borrmann, Clara Menéndez, Michael Nambozi, Innocent Valéa, Carolyn Nabasumba, Philip Sasi, Antonella Bacchieri, Marco Corsi, David Ubben, Ambrose Talisuna, and Umberto D'Alessandro
  
  PLoS One. 2009; 4(11): e7871. Published online 2009 November 17.
  
  
• Plasmodium falciparum Strains Harboring Dihydrofolate Reductase with the I164L Mutation Are Absent in Malawi and Zambia Even under Antifolate Drug Pressure
  
  Edwin Ochong, David J. Bell, David J. Johnson, Umberto D'Alessandro, Modest Mulenga, Sant Muangnoicharoen, Jean-Pierre Van Geertruyden, Peter A. Winstanley, Patrick G. Bray, Stephen A. Ward, and Andrew Owen
  
  Antimicrob Agents Chemother. 2008 November; 52(11): 3883–3888.Published online 2008 August 25.
  
  
• Safety profile of Coartem®: the evidence base
  
  Catherine Falade and Christine Manyando
  
  Malar J. 2009; 8(Suppl 1): S6. Published online 2009 October 12.
  
  
• 7 European and Developing Countries Clinical Trials Partnership (EDCTP): the path towards a true partnership
  
  Mecky I Matee, Christine Manyando, Peter M Ndumbe, Tumani Corrah, Walter G Jaoko, Andrew Y Kitua, Herman PA Ambene, Mathieu Ndounga, Lynn Zijenah, David Ofori-Adjei, Simon Agwale, Steven Shongwe, Thomas Nyirenda, and Michael Makanga
  
  BMC Public Health. 2009; 9: 249. Published online 2009 July 20.
  
  
• 8 Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone
  
  Julie A Simpson, Dyfrig Hughes, Christine Manyando, Kalifa Bojang, Leon Aarons, Peter Winstanley, Geoffrey Edwards, William A Watkins, and Steve Ward
  
  Br J Clin Pharmacol. 2006 March; 61(3): 289–300. Published online 2006 January 10.
  
  
• Early results of integrated malaria control and implications for the management of fever in under-five children at a peripheral health facility: a case study of Chongwe rural health centre in Zambia
  
  Pascalina Chanda, Busiku Hamainza, Susan Mulenga, Victor Chalwe, Charles Msiska, and Elizabeth Chizema-Kawesha
  
  Malar J. 2009; 8: 49. Published online 2009 March
  
  
• Supplementation has limited effects on intestinal infectious disease and mortality in a Zambian population of mixed HIV status: a cluster randomized trial1-3
  
  Paul Kelly, Max Katubulushi, Jim Todd, Rose Banda, Vera Yambayamba, Mildred Fwoloshi, Isaac Zulu, Emmanuel Kafwembe, Felistah Yavwa, Ian R Sanderson, and Andrew Tomkins
  
  Am J Clin Nutr. Author manuscript; available in PMC 2009 November 16.
  
  Published in final edited form as: Am J Clin Nutr. 2008 October; 88(4): 1010–1017.
  
  
• The vitamin A status of Zambian children in a community of vitamin A supplementation and sugar fortification strategies as measured by the modified relative dose response (MRDR) test.
  
  Kafwembe EM, Chipipa J, Njunju E, Chilengi R.
  
  Int J Vitam Nutr Res. 2009 Jan;79(1):40-7.

TDRC 2008 - 2007 PUBLICATIONS

• Effect of presumptive co-trimoxazole prophylaxis on pneumococcal colonization rates, seroepidemiology and antibiotic resistance in Zambian infants: a longitudinal cohort study.
  
  CJ Gill, V Mwanakasale, MP Fox, R Chilengi, M Tembo, M Nsofwa, V Chalwe, L Mwananyanda, D Mukwamataba, B Malilwe, D Champo, WB Macleod, DM Thea & DH Hamer.
  
  Bulletin of the World Health Organization; December 2008, 86 (12).
  
  
• Plasmodium falciparum strains harboring dihydrofolate reductase with the I164L mutation are absent in Malawi and Zambia even under antifolate drug pressure.
  
  Ochong E, Bell DJ, Johnson DJ, D'Alessandro U, Mulenga M, Muangnoicharoen S, Van Geertruyden JP, Winstanley PA, Bray PG, Ward SA, Owen A.
  
  Antimicrob Agents Chemother. 2008 Nov;52(11):3883-8. Epub 2008 Aug 25.
  
  
• Micronutrient supplementation has limited effects on intestinal infectious disease and mortality in a Zambian population of mixed HIV status: a cluster randomized trial.
  
  Kelly P, Katubulushi M, Todd J, Banda R, Yambayamba V, Fwoloshi M, Zulu I, Kafwembe E, Yavwa F, Sanderson IR, Tomkins A.
  
  Am J Clin Nutr. 2008 Oct;88(4):1010-7.
  
  
• Maize meal fortification is associated with improved vitamin A and iron status in adolescents and reduced childhood anaemia in a food aid-dependent refugee population.
  
  Seal A, Kafwembe E, Kassim IA, Hong M, Wesley A, Wood J, Abdalla F, van den Briel T.
  
  Public Health Nutr. 2008 Jul;11(7):720-8. Epub 2007 Dec 21.
  
  
• Impact of human immunodeficiency virus infection on Streptococcus pneumoniae colonization and seroepidemiology among Zambian women.
  
  Gill CJ, Mwanakasale V, Fox MP, Chilengi R, Tembo M, Nsofwa M, Chalwe V, Mwananyanda L, Mukwamataba D, Malilwe B, Champo D, Macleod WB, Thea DM, Hamer DH.
  
  J Infect Dis. 2008 Apr 1;197(7):1000-5.
  
  
• Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women.
  
  Gill CJ, Macleod WB, Mwanakasale V, Chalwe V, Mwananyanda L, Champo D, Mukwamataba D, Chilengi R, Thea DM, Hamer DH.
  
  J Infect Dis. 2007 Dec 1;196(11):1577-84. Epub 2007 Oct 25.
  
  
• Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.
  
  Hamer DH, Mwanakasale V, Macleod WB, Chalwe V, Mukwamataba D, Champo D, Mwananyanda L, Chilengi R, Mubikayi L, Mulele CK, Mulenga M, Thea DM, Gill CJ.
  
  J Infect Dis. 2007 Dec 1;196(11):1585-94. Epub 2007 Oct 25.
  
  
• High throughput functional analysis of HIV-1 env genes without cloning.
  
  Kirchherr JL, Lu X, Kasongo W, Chalwe V, Mwananyanda L, Musonda RM, Xia SM, Scearce RM, Liao HX, Montefiori DC, Haynes BF, Gao F.
  
  J Virol Methods. 2007 Jul;143(1):104-11. Epub 2007 Apr 9.
  
  
• Predominance of a single genotype of Mycobacterium tuberculosis in regions of Southern Africa.
  
  Chihota V, Apers L, Mungofa S, Kasongo W, Nyoni IM, Tembwe R, Mbulo G, Tembo M, Streicher EM, van der Spuy GD, Victor TC, van Helden P, Warren RM.
  
  Int J Tuberc Lung Dis. 2007 Mar;11(3):311-8.